Resource

2022 Vaccine Industry Consultation (VIC) – COVID-19

Presentations from the meeting that gathered vaccine manufacturers, partners and donors in June 2022 in Copenhagen.

Since the start of the COVID-19 outbreak, UNICEF has been working to procure and supply COVID-19 vaccines around the world, in collaboration with the PAHO Revolving Fund. Through the COVAX Facility – led by Gavi, the Vaccine Alliance, WHO and CEPI – UNICEF is working to secure global equitable access to COVID-19 vaccines.

On 3 June 2022, a specific Vaccine Industry Consultation dedicated exclusively to COVID-19 brought together vaccine manufacturers, partners and donors. The meeting was attended both online and in person and had the participation of several vaccine manufacturer’s representatives. It discussed lessons learned from the latest two years, the sector’s latest updates and provided a framework for consultations between industry and global partners.

Presentations

Supply and procurement update	Ann Ottosen, Senior Contracts Manager, UNICEF
The COVAX Facility	Derrick Sim, Director of Vaccines Demand and Supply and COVAX, Gavi
The wider picture: View from the Global Market Assessment Group	Ian Thornton, Individual Consultant, ACT-A COVAX Coordination Secretariat, O/P New York
COVID-19 Vaccine Delivery Partnership update	Benjamin Schreiber, PG Health Director’s Office, O/P Geneva
COVID-19 Supply and Procurement Roadmap, key sections	Margarita Xydia-Charmanta, Senior Supervisor, Strategy Development and Tenders, Market Shaping, Gavi
Approach for a procurement strategy beyond 2022	Siri Bjornstad, Contracts Manager, UNICEF
COVID-19 vaccines - Emergency Use Listing (EUL) updates	Carmen Rodriguez, Team Lead, Vaccines assessment and immunization devices, WHO
COVAX no-fault compensation program for AMC eligible economies	Rafael la Rotta, Insurance Risk Management Officer, WHO
The AVAT no-fault compensation scheme	Samallie Kiyingi, Director of Legal Services/General Counsel, African Export-Import Bank (Afreximbank)